-
FiberSmart is Genomic Vision’s Artificial Intelligence (AI) powered and fully integrated software automating genomic analysis
-
FiberSmart leverages cutting-edge AI to rapidly analyze DNA replication kinetics and provide a seamless user experience
-
FiberSmart platform was successfully tested by AstraZeneca and the Fritz Lipmann Institute
Genomic Vision, a Euronext-listed biotechnology company that develops products and services for the highly accurate characterization of DNA sequences, announced that its new integrated software FiberSmart has been successfully tested and validated by AstraZeneca, and the Fritz Lipmann Institute, Germany for the analysis of Replicating Combing Assay (RCA).
Recommended: Cisco and Emtrain Announce Partnership to Build a Conscious Workplace Culture for Hybrid Work
FiberSmart is an innovative, AI-based suite aimed at automating the detection and quantification of fluorescent signals on combed DNA molecules. Hundreds of thousands of RCA signals are automatically analyzed and rapidly compared while the end-user enjoys a seamless experience. The RCA is Genomic Vision’s proprietary method for the direct visualization of DNA replication kinetics at the single molecule level. FiberSmart has a simple and user-friendly interface, allowing users to quickly analyze DNA replication signals, deducing kinetics.
RCA is the first assay to be analyzed and automated with the FiberSmart software. It leverages state-of-the-art AI methods to visualize, detect and analyze DNA replication kinetics up to three times more accurately and up to ten times faster than Genomic Vision’s existing software solutions.
Aaron Bensimon, Chief Executive Officer of Genomic Vision, commented: “The successful beta testing of FiberSmart for the analysis of DNA replication kinetics is an important milestone for all our partners who can now perform faster and more accurate analysis using the RCA with a seamless experience. Along with RCA, our proprietary DNA combing technique has multiple potential applications, and we look forward to expanding FiberSmart’s capabilities to empower our users to perform faster more accurate analyses.”
Recommended: Moveworks’ AI Platform Powers Jamf’s New Standard for Hybrid Work Support
Helmut Pospiech, Ph.D., Senior Research Fellow at Fritz Lipmann Institute, commented: “FiberSmart sets new standards in the analysis and quantification of Replication Combing Assays as it offers automated recognition of DNA structures, as well as ease and speed of use.”
The software is compatible with Genomic Vision’s suite of scanners FiberVision and FiberVision-S. FiberSmart for the RCA application will be launched in the coming weeks.
GENOMIC VISION is a biotechnology company developing products and services dedicated to the analysis (structural and functional) of genome modifications as well as to the quality and safety control of these modifications, in particular in genome editing technologies and biomanufacturing processes. Genomic Vision proprietary tools, based on DNA combing technology and artificial intelligence, provide robust quantitative measurements needed to high confidence characterization of DNA alteration in the genome. These tools are mainly used for monitoring DNA replication in cancerous cell, for early cancer detection and the diagnosis of genetic diseases.
Recommended: AnyClip to Power Zoom’s Ai-Driven “Smart Video” Center for Global Partners
[To share your insights with us, please write to sghosh@martechseries.com]
Comments are closed.